Vetter Aligns its Development Service Laboratory Portfolio Under One Roof

  • Bundling of competencies optimizes workflow of customer projects
  • Further expansion of laboratory space to continue through 2020
  • Company continues to invest strongly in its future

Ravensburg, Germany, Vetter, a global operating Contract Development and Manufacturing Organization (CDMO) has brought together its development laboratories in one Ravensburg site end of last year. Designed to improve workflow and enhance customer benefits within the daily support in complex development projects, the services at the 1,800 sqm building include process development as well as functional and specification testing of packaging systems, chemical-analytical and biochemical analysis and particle characterization. State-of-the-art non-GMP laboratory space and equipment combined with a leading-edge GMP analytical laboratory now allow for increased capacity and optimized work spaces.

At present, more than fifty employees work in the new labs. By bringing the laboratories under one roof, employees easily share expertise and know-how to improve and simplify information exchange, leverage synergies and reinforce an overall positive work atmosphere. Overall customer will benefit from the alignment. Prior to the bundling of its laboratories, the development studies and the corresponding analytical services for testing during process or packaging material development took place in several labs at different locations in Ravensburg and Langenargen. By sequencing these services, processes have been synchronized and handling issues reduced, all leading to numerous benefits primarily for customer projects, but also for projects undertaken within the company.

“Our customers are excited and impressed with the new and modern development laboratories and their increased capacity. Now they can follow a complete development process and its individual steps, since it proceeds throughout the labs, all within the same building,” said Dr. Claus Feussner, Senior Vice President Development Service. Expansion will continue within the building throughout the year and includes still more lab space and the provision of additional innovative analytical equipment and lyophilizer capacity.

Vetter is also committed to further process optimization and capacity expansion in filling and secondary packaging of injectables at all its sites. This is based on increased global customer demand for the development and commercialization of promising new compounds.





Vetter Pharma International GmbH 

Markus Kirchner 

Corporate Spokesperson / Media Relations 

Eywiesenstrasse 5 

88212 Ravensburg 


Phone: +49 (0)751-3700-3729 





Vetter Pharma-Fertigung GmbH & Co. KG, Schützenstrasse 87, 88212 Ravensburg, Germany
Sitz in Ravensburg, eingetragen im Registergericht Ulm HRA 550954,
persönlich haftende Gesellschafterin: Vetter Pharma-Fertigung Verwaltungs GmbH
Geschäftsführer: Thomas Otto, Peter Sölkner

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.


Headquartered in Ravensburg, Germany, Vetter is a global leading contract development and manufacturing organization (CDMO) with production facilities in Germany and the United States. Currently employing 4,900 individuals worldwide, the company has long-term experience in supporting biotechnology and pharmaceutical customers both large and small. Vetter services range from early stage development support including clinical manufacturing, to commercial supply and numerous packaging solutions for vials, syringes and cartridges.